Max Healthcare Institute Sees High Value Trading Amid Rising Investor Interest

On 19 Nov 2025, Max Healthcare Institute recorded a total traded volume of 26,14,369 shares, translating into a substantial traded value of approximately ₹29,828.64 lakhs. This level of activity places the stock among the top equities by value turnover, underscoring its liquidity and appeal to institutional and retail investors alike. The stock opened at ₹1,115.0 and touched an intraday high of ₹1,154.1, representing a 3.35% rise from the opening price. The last traded price (LTP) stood at ₹1,153.8 as of 11:33:46 IST, with the day’s low recorded at ₹1,104.9.

In comparison to the hospital sector’s 1-day return of 0.74% and the Sensex’s marginal 0.16% gain, Max Healthcare Institute’s 1-day return of 3.32% highlights its relative outperformance. This performance was further supported by the stock’s movement above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remained below the 100-day moving average, indicating a mixed technical picture that investors may wish to monitor closely.

Investor participation has shown a marked increase, with delivery volumes reaching 33.58 lakhs on 18 Nov 2025. This figure represents a rise of 101.89% compared to the 5-day average delivery volume, signalling a surge in genuine buying interest rather than speculative trading. Such a trend often points to institutional involvement or large order flows, which can be a key driver of price momentum in large-cap stocks like Max Healthcare Institute.

Liquidity remains a strong feature for Max Healthcare Institute, with the stock’s traded value representing approximately 2% of its 5-day average traded value. This translates into a trade size capacity of around ₹8.49 crores, making it suitable for sizeable transactions without significant market impact. Such liquidity is crucial for institutional investors and large traders seeking to execute orders efficiently.

From a market capitalisation perspective, Max Healthcare Institute is classified as a large-cap stock with a market cap of ₹1,10,125 crores. This sizeable valuation places it among the leading companies in the hospital sector, which itself is a critical component of the broader healthcare industry in India. The hospital sector has been under close scrutiny due to evolving healthcare demands and policy changes, making stocks like Max Healthcare Institute focal points for investors analysing sectoral trends.

The stock’s day change of 4.03% on 19 Nov 2025 further emphasises the dynamic trading environment surrounding Max Healthcare Institute. This movement reflects the interplay of various factors including institutional interest, large order flows, and market sentiment towards the hospital sector. The company’s mojo score of 43.0 and a recent adjustment in its mojo grade from Hold to Sell as of 31 Oct 2025 indicate a revision in its evaluation, which market participants may consider alongside trading activity and price action.

Analysing the price summary for the day, the weighted average price indicates that a larger volume of shares traded closer to the day’s low price, suggesting some selling pressure at higher levels. However, the overall price trajectory remained positive, with the stock outperforming its sector by 2.47%. This outperformance relative to peers in the hospital sector may reflect company-specific developments or broader investor confidence in Max Healthcare Institute’s operational prospects.

Given the hospital sector’s strategic importance and the evolving healthcare landscape in India, Max Healthcare Institute’s trading activity offers valuable insights into market dynamics. The stock’s liquidity, combined with rising delivery volumes and significant value turnover, points to active participation by institutional investors and large traders. These factors contribute to the stock’s prominence among the most active equities by value on the trading day.

Investors analysing Max Healthcare Institute should consider the interplay of technical indicators, trading volumes, and sectoral context. While the stock’s mojo grade revision signals a change in evaluation, the strong trading volumes and relative price strength highlight ongoing market interest. Monitoring these elements alongside broader market trends will be essential for informed decision-making.

In summary, Max Healthcare Institute’s performance on 19 Nov 2025 underscores its role as a key player in the hospital sector with substantial trading activity and investor engagement. The stock’s liquidity and value turnover make it a focal point for market participants seeking exposure to healthcare services within India’s large-cap universe.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →